MX2009003257A - Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina. - Google Patents
Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.Info
- Publication number
- MX2009003257A MX2009003257A MX2009003257A MX2009003257A MX2009003257A MX 2009003257 A MX2009003257 A MX 2009003257A MX 2009003257 A MX2009003257 A MX 2009003257A MX 2009003257 A MX2009003257 A MX 2009003257A MX 2009003257 A MX2009003257 A MX 2009003257A
- Authority
- MX
- Mexico
- Prior art keywords
- synthesis
- diaminopyrimidine derivatives
- phenoxy
- phenoxy diaminopyrimidine
- derivatives
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- IBEQALXTSLPKDO-UHFFFAOYSA-N O(C1=CC=CC=C1)C1=NC(=CC(=N1)N)N Chemical class O(C1=CC=CC=C1)C1=NC(=CC(=N1)N)N IBEQALXTSLPKDO-UHFFFAOYSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000012453 solvate Substances 0.000 abstract 2
- 229910021529 ammonia Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Abstract
Se describe un método para preparar un compuesto de la fórmula k o una sal o solvato del mismo, en donde R1 es como se define en la presente, el método comprende tratar un compuesto de la fórmula j o una sal o solvato del mismo, con amoniaco, para formar el compuesto de la fórmula k.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84920306P | 2006-10-04 | 2006-10-04 | |
| PCT/EP2007/060095 WO2008040652A1 (en) | 2006-10-04 | 2007-09-24 | Process for synthesis of phenoxy diaminopyrimidine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009003257A true MX2009003257A (es) | 2009-04-07 |
Family
ID=39004835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009003257A MX2009003257A (es) | 2006-10-04 | 2007-09-24 | Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina. |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US8003788B2 (es) |
| EP (2) | EP2343281B1 (es) |
| JP (2) | JP5128603B2 (es) |
| KR (1) | KR101176701B1 (es) |
| CN (2) | CN101522641B (es) |
| AU (1) | AU2007304280B2 (es) |
| BR (1) | BRPI0719955B1 (es) |
| CA (1) | CA2664305C (es) |
| DK (1) | DK2343281T3 (es) |
| ES (2) | ES2466667T3 (es) |
| IL (3) | IL197639A (es) |
| MX (1) | MX2009003257A (es) |
| PL (1) | PL2343281T3 (es) |
| SI (1) | SI2343281T1 (es) |
| WO (1) | WO2008040652A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2466667T3 (es) * | 2006-10-04 | 2014-06-10 | F. Hoffmann-La Roche Ag | Proceso para síntesis de derivados de fenoxi diaminopirimidina |
| CA2921395C (en) | 2013-08-23 | 2022-04-26 | Afferent Pharmaceuticals Inc. | Diaminopyrimidine p2x3 and p2x 2/3 receptor modulators for treatment of acute, sub-acute or chronic cough |
| CN105085847B (zh) * | 2014-05-23 | 2018-05-04 | 中国科学院宁波材料技术与工程研究所 | 一种磺酰胺化芳香族聚合物、其制备方法及应用 |
| EP3981406A1 (en) | 2014-07-03 | 2022-04-13 | Afferent Pharmaceuticals Inc. | Methods and compositions for treating diseases and conditions |
| PT3355889T (pt) * | 2015-09-29 | 2023-04-26 | Afferent Pharmaceuticals Inc | Moduladores de recetores de diaminopirimidina p2x3 e p2x2/3 para utilização no tratamento da tosse |
| CN108779119B (zh) | 2016-03-25 | 2022-02-08 | 传入制药公司 | 嘧啶及其变体、及其用途 |
| CN110087654A (zh) | 2016-12-20 | 2019-08-02 | 传入制药公司 | P2x3拮抗剂的结晶盐和多晶型物 |
| AU2019257606B2 (en) * | 2018-04-23 | 2025-01-30 | Msd Werthenstein Biopharma Gmbh | Novel process for synthesis of a phenoxy diaminopyrimidine compound |
| SG11202111877TA (en) | 2019-04-30 | 2021-11-29 | Beijing Tide Pharmaceutical Co Ltd | Method for treating cough by using diaminopyrimidine compound |
| CN111635368B (zh) * | 2020-06-12 | 2021-06-29 | 东莞市东阳光仿制药研发有限公司 | 一种胺化合物的制备方法 |
| EP4214195A1 (en) | 2020-09-17 | 2023-07-26 | Teva Pharmaceuticals International GmbH | Solid state forms of gefapixant and process for preparation thereof |
| CN113336680B (zh) * | 2021-06-04 | 2023-10-03 | 寿光永康化学工业有限公司 | 一种磺胺的绿色工艺合成方法 |
| CN113801097B (zh) * | 2021-09-27 | 2022-11-22 | 成都施贝康生物医药科技有限公司 | 二氢嘧啶类化合物、其制备方法及用途 |
| CN113773300B (zh) * | 2021-09-27 | 2022-10-11 | 成都施贝康生物医药科技有限公司 | 磺酰胺类化合物、其制备方法及用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3117721B2 (ja) * | 1994-11-24 | 2000-12-18 | エフ・ホフマン−ラ ロシュ アーゲー | 新規なベンジルピリミジン類 |
| AUPQ968700A0 (en) * | 2000-08-28 | 2000-09-21 | Intreat Pty Limited | Treatment of urinary incontinence |
| AU2003252509A1 (en) * | 2002-07-29 | 2004-02-16 | Sumitomo Chemical Takeda Agro Company, Limited | NOVEL PROCESS FOR PRODUCING IMIDAZO(1,2-b)PYRIDAZINE DERIVATIVE |
| ES2548022T3 (es) * | 2004-03-05 | 2015-10-13 | F. Hoffmann-La Roche Ag | Diaminopirimidinas como antagonistas de P2X3 y P2X2/3 |
| SE0401716D0 (sv) * | 2004-07-02 | 2004-07-02 | Astrazeneca Ab | New compounds |
| US7544702B2 (en) * | 2004-08-12 | 2009-06-09 | Amgen Inc. | Bisaryl-sulfonamides |
| JP4246207B2 (ja) * | 2005-02-21 | 2009-04-02 | 住友化学株式会社 | 除草剤組成物 |
| CA2620033C (en) * | 2005-09-01 | 2014-12-02 | Anton Constantinescu | Process for synthesis of aryloxy diaminopyrimidines |
| KR101012926B1 (ko) * | 2005-09-01 | 2011-02-09 | 에프. 호프만-라 로슈 아게 | Ｐ2ｘ3 및 ｐ2ｘ2/3 조정자로서의 다이아미노피리미딘 |
| ES2466667T3 (es) * | 2006-10-04 | 2014-06-10 | F. Hoffmann-La Roche Ag | Proceso para síntesis de derivados de fenoxi diaminopirimidina |
| WO2008104474A1 (en) * | 2007-02-28 | 2008-09-04 | F. Hoffmann-La Roche Ag | Diaminopyrimidines |
-
2007
- 2007-09-24 ES ES07820502.8T patent/ES2466667T3/es active Active
- 2007-09-24 EP EP10180595.0A patent/EP2343281B1/en active Active
- 2007-09-24 PL PL10180595T patent/PL2343281T3/pl unknown
- 2007-09-24 CA CA2664305A patent/CA2664305C/en active Active
- 2007-09-24 CN CN2007800373077A patent/CN101522641B/zh active Active
- 2007-09-24 WO PCT/EP2007/060095 patent/WO2008040652A1/en not_active Ceased
- 2007-09-24 BR BRPI0719955-4A patent/BRPI0719955B1/pt active IP Right Grant
- 2007-09-24 AU AU2007304280A patent/AU2007304280B2/en active Active
- 2007-09-24 JP JP2009530844A patent/JP5128603B2/ja active Active
- 2007-09-24 CN CN2011103315372A patent/CN102432548A/zh active Pending
- 2007-09-24 ES ES10180595.0T patent/ES2461595T3/es active Active
- 2007-09-24 KR KR1020097008196A patent/KR101176701B1/ko active Active
- 2007-09-24 EP EP07820502.8A patent/EP2079713B1/en active Active
- 2007-09-24 DK DK10180595.0T patent/DK2343281T3/en active
- 2007-09-24 SI SI200731458T patent/SI2343281T1/sl unknown
- 2007-09-24 MX MX2009003257A patent/MX2009003257A/es active IP Right Grant
- 2007-10-04 US US11/906,802 patent/US8003788B2/en active Active
-
2009
- 2009-03-17 IL IL197639A patent/IL197639A/en active IP Right Grant
-
2011
- 2011-07-12 US US13/181,305 patent/US8580960B2/en active Active
-
2012
- 2012-09-05 JP JP2012194914A patent/JP5669793B2/ja active Active
-
2013
- 2013-10-14 US US14/053,362 patent/US9643934B2/en active Active
-
2014
- 2014-09-09 IL IL234545A patent/IL234545A/en active IP Right Grant
-
2017
- 2017-09-11 IL IL254426A patent/IL254426A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009003257A (es) | Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina. | |
| MX337588B (es) | Metodo para preparar derivados de 5-haloalquil-4,5-dihidroisoxasol . | |
| MX2009005616A (es) | Derivados de pirido-pirazina utiles como compuestos herbicidas. | |
| MY160785A (en) | Manufacturing process for pyrimidine derivatives | |
| AU2015221439B2 (en) | Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same | |
| MX2009014104A (es) | Metodos para sintetizar cinacalcet y sales del mismo. | |
| MX2009003739A (es) | Derivados de hidrobenzamida como inhibidores de hsp90. | |
| NZ593874A (en) | Nalmefene hydrochloride dihydrate | |
| WO2009154754A3 (en) | Synthesis of deuterated morpholine derivatives | |
| GEP20125512B (en) | Process for synthesis of agomelatin | |
| MXPA05013751A (es) | Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales. | |
| IL178771A0 (en) | 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides | |
| IL185545A0 (en) | Method of preparation of pure 4-pyrrolidinophenylbenzyl ether derivatives as maob inhibitors | |
| MX2011011025A (es) | Preparacion de c-piracin-metilaminas. | |
| TW201129550A (en) | Method for producing diepoxy compound | |
| TW200720366A (en) | Process for preparing metal compounds of an azo compound in the presence of seed crystals | |
| EA201001252A1 (ru) | Способ получения производных 3,6-дигидро-1,3,5-триазина | |
| TW201129575A (en) | Metal complex having pyridylphosphine compound, and method for producing alkyl methacrylate | |
| TW200612959A (en) | Method for preparing hydroxamic acids | |
| ZA200800138B (en) | Process for the preparation of crystalline perindopril | |
| TW200738650A (en) | Process for synthesis of aryloxy diaminopyrimidines | |
| WO2012015255A3 (en) | Novel montelukast 4-halobenzylamine salt and method for preparing montelukast sodium salt by using the same | |
| NZ589496A (en) | Processes and compounds for the preparation of normorphinans | |
| MX2009013336A (es) | Sintesis de 3-aminopirazoles sustituidos. | |
| UA102091C2 (ru) | Способ получения сульфонилпиролов как ингибиторов hdac |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |